Publications by authors named "Charles Bennett"

Claim this Profile
M
Meta-analysis on the effects of client preferences on treatment satisfaction, completion, and clinical outcome: A 10-year update.
Charles B Bennett, Emma K Toevs, Abby Angus, Rebecca Krawczak, Christopher J Trentacosta

Clin Psychol Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concerns regarding "GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes".
Chien-Hsiang Weng, Charles L Bennett, Joseph Magagnoli, Chien-Chih Chou, Philip A Chan

Diabetes Obes Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Requirements for Interchangeable Biosimilar Designation.
Praveen J Samy, Morgane C Mouslim, Charles L Bennett, Antonio J Trujillo

Ther Innov Regul Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP Inhibitors in Metastatic Castrate-Resistant Prostate Cancer.
Charles L Bennett, June M McKoy

JAMA Netw Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Marketing Safety Assessment for Glucagon-Like Peptide-1 and Dual Incretin Therapies in Diabetes and Obesity.
Chien-Hsiang Weng, Charles L Bennett, Joseph Magagnoli, Caroline Richardson

J Clin Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Inflation Reduction Act and Etanercept.
Charles L Bennett, Jason B Gibbons, Chadi Nabhan, Kenneth R Carson, June M McKoy

Arthritis Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to a Supplement From the Cancer Journal: The Journal of Principles and Practice of Oncology.
Charles L Bennett, Kevin B Knopf

Cancer J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigating the Impact of Drug Shortages in Oncology: Lessons Learned From the 2023 Shortages of Carboplatin and Cisplatin.
Maxwell L Izen, June M McKoy, Linda Martin, Chadi Nabhan, Gretchen LeFever Watson, Charles L Bennett

Cancer J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Drugs and United States Tariffs: Attention Must Be Paid.
Maxwell L Izen, June M McKoy, Linda Martin, Chadi Nabhan, Gretchen LeFever Watson, Charles L Bennett

Cancer J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Stockpiling of Pediatric Cancer Medications in the United States: An Alternative Approach to Hospital-Based Storage for Essential Oncology Drugs.
Maxwell L Izen, Mia Lynch, Charles L Bennett

Cancer J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study.
Chien-Hsiang Weng, Philip A Chan, Joseph Magagnoli, Charles L Bennett

Drug Saf· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why did it take forty years to uncover long-term fluoroquinolone associated toxicities?
Charles L Bennett, Linda Martin, Gretchen LeFever Watson, Steven T Rosen, David Aboulafia

Eur J Intern Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review.
Joseph Magagnoli, Kevin Knopf, William J Hrushesky, Kenneth R Carson, Charles L Bennett

Am J Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatric factors predict type 2 diabetes mellitus in US Veterans.
Lora Lee Pless, Chantele Mitchell-Miland, Yeon-Jung Seo, Charles B Bennett, Zachary Freyberg

Schizophrenia (Heidelb)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valuing Clinical Strategies Immediately After FDA Approval.
Charles L Bennett, Kevin B Knopf

JAMA Netw Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseases.
Charles L Bennett, Joseph Magagnoli, Krishna Gundabolu, Peter Georgantopoulos, Akida Lebby

PLoS One· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide.
Charles L Bennett, Jason B Gibbons, Antonio Trujillo, Kenneth R Carson, Kevin Knopf

JCO Oncol Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer With Abiraterone or Enzalutamide.
Forest Riekhof, Yan Yan, Charles L Bennett, Kristen M Sanfilippo, Kenneth R Carson

Clin Genitourin Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjusting starting points for initial price offers: the example of ibrutinib.
Jason B Gibbons, Charles L Bennett, Kenneth R Carson, Gerard F Anderson

Am J Manag Care· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the Drug-Shortage Crisis in Oncology.
Y Tony Yang, Mariana Socal, Charles L Bennett

JAMA Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases.
Martin W Schoen, Kenneth R Carson, Seth A Eisen, Charles L Bennett, Suhong Luo

Prostate Cancer Prostatic Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
United States' regulatory approved pharmacotherapies for nuclear reactor explosions and anthrax-associated bioterrorism.
Charles L Bennett, Peter Georgantopoulos, Robert Peter Gale, Kevin Knopf, William J Hrushesky

Expert Opin Drug Saf· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Recurrence After Radiation in Early Prostate Cancer-Role of Risk Stratification From Prospective Trials.
Martin W Schoen, Charles L Bennett

JAMA Netw Open· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing FDA-accelerated approval of single-arm trials in oncology (1992 to 2020).
Tatiane Bomfim Ribeiro, Charles L Bennett, Luis Enrique Colunga-Lozano, Ana Paula Vieira Araujo, Iztok Hozo

J Clin Epidemiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis